Structure of the intact transactivation domain of the human papillomavirus E2 protein

被引:88
|
作者
Antson, AA
Burns, JE
Moroz, OV
Scott, DJ
Sanders, CM
Bronstein, IB
Dodson, GG
Wilson, KS [1 ]
Maitland, NJ
机构
[1] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England
[2] Univ York, Dept Biol, YCR Canc Res Unit, York YO10 5DD, N Yorkshire, England
[3] Natl Inst Med Res, London NW7 1AA, England
关键词
D O I
10.1038/35001638
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Papillomaviruses cause warts and proliferative lesions in skin and other epithelia. In a minority of papillomavirus types ('high risk'. including human papillomaviruses 16, 18, 31, 33, 45 and 56), further transformation of the wart lesions can produce tumours'. The papillomavirus E2 protein controls primary transcription and replication of the viral genome(2). Both activities are governed by a similar to 200 amino-acid amino-terminal module (E2NT) which is connected to a DNA-binding carboxy-terminal module by a flexible linker. Here we describe the crystal structure of the complete E2NT module from human papillomavirus 16. The E2NT module forms a dimer both in the crystal and in solution. Amino acids that are necessary for transactivation are located at the dimer interface, indicating that the dimer structure may be important in the interactions of E2NT with viral and cellular transcription factors. We propose that dimer formation may contribute to the stabilization of DNA loops(3) which may serve to relocate distal DNA-binding transcription factors to the site of human papillomavirus transcription initiation.
引用
收藏
页码:805 / 809
页数:5
相关论文
共 50 条
  • [21] THE CRYSTAL STRUCTURE OF THE HUMAN PAPILLOMAVIRUS 31 E2 DNA BINDING DOMAIN IN THE ABSENCE OF DNA.
    Giranda, V. L.
    Kong, X.
    Egan, D.
    Lindh, F.
    Holzman, T.
    Yoon, H. S.
    Robins, T.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C156 - C156
  • [22] Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 Å
    Bussiere, DE
    Kong, XP
    Egan, DA
    Walter, K
    Holzman, TF
    Lindh, F
    Robins, T
    Giranda, VL
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1998, 54 : 1367 - 1376
  • [23] Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions
    Sakai, H
    Yasugi, T
    Benson, JD
    Dowhanick, JJ
    Howley, PM
    JOURNAL OF VIROLOGY, 1996, 70 (03) : 1602 - 1611
  • [24] Interaction of Daxx and human papillomavirus type 16 E2 protein
    Tang, S. Y.
    Li, L.
    Liu, Y.
    Liu, A. Y.
    Yu, M. J.
    Zhang, Y.
    Liu, L. Z.
    Wan, Y. P.
    MOLECULAR BIOLOGY, 2014, 48 (04) : 594 - 598
  • [25] Design and characterization of an enhanced repressor of human papillomavirus E2 protein
    Bose, Kakoli
    Meinke, Gretchen
    Bohm, Andrew
    Baleja, James D.
    FASEB JOURNAL, 2011, 25 (07): : 2354 - 2361
  • [26] Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: Evidence for flexible DNA-binding regions
    Liang, H
    Petros, AM
    Meadows, RP
    Yoon, HS
    Egan, DA
    Walter, K
    Holzman, TF
    Robins, T
    Fesik, SW
    BIOCHEMISTRY, 1996, 35 (07) : 2095 - 2103
  • [27] The human papillomavirus 16 E2 protein is stabilised in S phase
    Johansson, Cecilia
    Graham, Sheila V.
    Dornan, Edward S.
    Morgan, Iain M.
    VIROLOGY, 2009, 394 (02) : 194 - 199
  • [28] Papillomavirus E2 protein interacts with and stimulates human topoisomerase I
    Clower, RV
    Hu, Y
    Melendy, T
    VIROLOGY, 2006, 348 (01) : 13 - 18
  • [29] Interaction of Daxx and human papillomavirus type 16 E2 protein
    S. Y. Tang
    L. Li
    Y. Liu
    A. Y. Liu
    M. J. Yu
    Y. Zhang
    L. Z. Liu
    Y. P. Wan
    Molecular Biology, 2014, 48 : 594 - 598
  • [30] Evolutionary variation of papillomavirus E2 protein and E2 binding sites
    Rogers, Adam
    Waltke, Mackenzie
    Angeletti, Peter C.
    VIROLOGY JOURNAL, 2011, 8